Date

Friday, 19 April 2024, 10:00 (CEST) - 12:30 (CEST)

Location

European Medicines Agency, Amsterdam, the Netherlands
Live Broadcast

Event summary

The EU Innovation Network, in conjunction with ACT EU, is organising an information and training webinar on Simultaneous National Scientific Advice (SNSA) to be held on 19th April 2024.

The objectives of the webinar are to:

  • provide information on the ongoing SNSA pilot, including the rationale behind this initiative and experience to date;
  • outline the circumstances in which SNSA could be used, including some case studies;
  • summarise the optimised procedure for phase 2 of the SNSA pilot;
  • highlight the benefits for applicants;
  • answer questions and invite feedback from stakeholders in relation to SNSA.

This EMA-hosted webinar anticipates a broad representation of stakeholders who may benefit from using SNSA including pharmaceutical companies, SMEs, and non-commercial or academic researchers and developers, funding bodies, etc.

No certificates of attendance will be issued for this event.

The event will be broadcast live. A video recording will be made available after the event. Processing and publication of the video recording typically takes up to 60 days.

Documents

Live broadcast

You should see the live broadcast on pressing the 'play' icon in the video window, or a message stating that the event has not started yet.

To optimise video quality, once the video is playing we recommend clicking on the ‘Wheel’ symbol in the video window then selecting the Quality Option up to 1080p.

If the video window is blank, or if you experience other difficulties viewing the broadcast, please try connecting directly to the EMA's Vimeo Channel 1.

For technical information about the required network security settings, please see this Vimeo help page.

For further assistance, please consult the EMA Service desk.

Participation via Slido

A qr code on a white background

Description automatically generatedParticipants are encouraged to use Slido to submit questions in advance of the webinar. The most popular questions will be answered by speakers during the Q & A session.

Please provide your questions between 25 March – 12 April 2024.

 

How useful do you find this page?